Prenatal Genetics Flashcards

1
Q

Prenatal Diagnosis

A
  • medical evaluation of a fetus- that provides both physical and genetic information
  • genetic testing has the capability to diagnose fetal disease
  • prior to testing, parents should be counseled about the reasons to do the test and the possible outcomes
  • depending on the type of test, there could be a risk to the mom and to the pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Indications for Prenatal Diagnosis-Inherited

A
  • familial chromosome anomaly
  • family history of a genetic disorder for which testing is available
  • Familial X linked recessive disorder without testing available
  • increased risk of ONTD (recurrence risk 2-5%)
  • carrier of genetic disorder, ethnic risk
  • consanguinity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Other Reasons for Prenatal Diagnosis

A
  • ultrasound anomaly
  • repeated miscarriages
  • Abnormal MSAFP (maternal serum alphafetoprotein)
  • anxiety
  • environmental exposures
  • increased risk of a chromosomal abnormality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Relative Frequency of Types of Aberration

A
  • most common live birth anomaly is trisomy 21
  • most common aneuploidy is 45,X
  • most common autosomal aneuploidy is trisomy 16
  • triploidy is the third highest frequency cause of fetal loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Spontaneous termination frequencies

A
  • 95% of 45,X conceptions
  • 90% of trisomy 12 conceptions
  • 80% of trisomy 18 conceptions
  • 65% of trisomy 21 conceptions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tests available

A
  • examination
  • ultrasound
  • cytogenetics
  • biochemical
  • molecular studies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

invasive vs non-invasive tests

A
  • in general, non-invasive is better than invasive- less risk to the fetus
  • want the most specific information at the least risk
  • types of testing performed depends on clinical indication- and what information needs to be collected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ultrasound

A
  • verify viability
  • detect a multiple pregnancy
  • determines the gestational age
  • determine the sex
  • identify possible abnormalities
  • may indicate that additional studies are needed
  • usually performed around 18 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nuchal translucency

A
  • indicator on ultrasound of a possible abnormality in a fetus like chromosomal
  • thickness of 6.0 mm has been associated with Down syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clefting

A

-unilateral or bilateral cleft lip, cleft palate, or both can be detected on ultrasound and are usually indicators of a genetic defect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neural tube defects

A
  • can be detected on ultrasounds
  • like a meningomyelocele
  • range of severity
  • less severe forms may be corrected surgically, more severe can be debilitating
  • closed: skin is intact
  • open: rupture in the skin (spinal fluid mix with amniotic fluid)
  • severe ones like anencephaly- absence of the brain and is lethal
  • encephalocele when the brain is extruded from the skull
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Maternal Serum Alphafetoprotein

A
  • 15-20 weeks
  • high, low, normal
  • gestational age
  • mother’s weight, race, diabetic status
  • produced by fetal liver and crosses the placenta and can be detected in maternal circulation
  • AFP is correlated to the stage of gestation
  • risk assessment
  • low levels: Down syndrome
  • high levels: ONTD- open tubular defects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Maternal Serum Quad Test

A
  • 4 different substances
  • alpha fetoprotein low
  • hCG up
  • unconjugated estrol low
  • dimeric inhibin up
  • 80% combined detection for DS
  • can be used up to 40 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Integrated Prenatal Testing

A
  • 10-13 weeks gestation:
  • PAPP-A (pregnancy-associated plasma protein A, when lower associated with increased risk of DS)
  • nuchal translucency
  • 15-21 weeks gestation the Quad MSAFP testing is performed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Non-invasive Prenatal Screening/Testing

A
  • the newst non-invasive assay is know as NIPS
  • cffDNA= cell free fetal/placental DNA
  • isolated from maternal blood at 10-22 weeks gestation
  • 10-15% of cfDNA in maternal blood is fetal in origin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Technology

A
  • sequencing to identify DNA fragments
  • determine chromosomal source of each fragment
  • statistically analyze the number of fragments per chromosome compared to expected number for mother and fetus
17
Q

Detection of Aneusomy

A
  • the expected amounts of DNA per chromosome are analyzed, and any increase or decrease in the total value for a particular chromosome would suggest an aneuploidly
  • the numbers are very small, so the hardware and software have to be precise
  • it is a screening test that gives a risk for a chromosomal abnormality
  • if the numbers are out of bounds it has to be confirmed by a diagnostic test which is usually a karyotype analysis and/or FISH
18
Q

NIPS accuracy

A
  • DS (+21) and trisomy 18:99%
  • trisomy 13:72-92%
  • XX: 98.4%
  • XY: 99%
  • abnormals should be confirmed
  • 0.5-7 failure rate- due to insufficient fetal DNA
19
Q

Amniocentesis

A
  • needle inserted through abdomen into the amniotic cavity
  • 14-20 weeks gestation- usually done 16-18 weeks, can be done as late as 35 weeks
  • risk at 1/200
  • test possible- AFAFP, cytogenetics, metabolic assays, molecular diagnostics
20
Q

Low AFP Levels

A
  • Trisomies 13, 18, 21
  • Mosaic Turner syndrome
  • Triploidy
  • Unbalanced translocations
21
Q

Elevated AFP Levels

A
  • increased risk of ONTD
  • acetylcholineesterase is the confirmatory test
  • AChE should only be present in amniotic fluid if there is a defect in the neural tube
22
Q

AFP testing is for screening ONLY

A
  • confirmatory tests
  • elevated AFP associated with ONTD- elevation in acetylcholinesterase in the amniotic fluid
  • low AFP- chromosomal disorders, specifically Down Snydrome, karyote analysis
23
Q

Chorionic Villus Sampling

A
  • 10-14 weeks gestation
  • limb reduction when done <10 weeks
  • risk 1/100
  • cytogenetics, molecular diagnostics, metabolic (cells only)
  • usually works because fetus and placenta come from same zygote (unless mosaicism)- abnormal CVS test may merely mean there is a problem with the placenta
24
Q

Localized Mutation- Placental

A
  • -if a mutation occurs only in the layer of cells that will become the placenta, the fetus may be perfectly fine
  • all or part of the placenta may carry the mutation
  • if only part of the placenta has a mutation, it is called confined placental mosaicism
  • a mutation in the placenta may or may not affect the development of the fetus
  • if the placenta is sufficiently compromised if may not support fetal development
  • if a CVS is done and detects a mutation, it could result in a misinterpretation of the fetal status
25
Q

Confined Fetal Mutation

A
  • if the only cells with the mutation occur in the fetus, then the CVS testing will miss that all together
  • this risk is low since this doesn’t occur very often, but whenever CVS testing is done early, it is important to continue to monitor the pregnancy
  • the fetus may be completely abnormal or only some of the cells may have the mutation
26
Q

Why choose CVS

A

-if a couple wants to know early if there is a problem so that they have the option of termination of pregnancy, this is the testing method of choice

27
Q

Outcomes of Prenatal Diagnosis

A
  • no anomalies in 98% of cases
  • termination
  • fetal treatment in utero
  • IVF
28
Q

Assisted Reproductive Technologies

A
  • IVF
  • intracytoplasmic sperm insertion
  • zygote intrafallopian transfer
  • donor egg
29
Q

Polar Body Analysis

A
  • polar body can be collected and tested with no ill effects to the oocyte
  • a polar body can be collected and tested with no ill effects to the oocyte
  • if the 1st polar body tests positive for the CF mutation known to be carried by the mom than the corresponding egg would be expected to have CF mutation
30
Q

Preimplantation Genetic Diagnosis

A
  • polar body analysis is difficult so prenatal genetic diagnosis was developed
  • screening technique for embryos
  • unsatisfactory = destroyed
  • eggs collected and fertilized in vitro, at 8 cell stage a single cell is separated out and tested by FISH or molecular assay
31
Q

Next generation screeening

A
  • replace PGD because it is a whole genome screen

- 3000-5000 dollars

32
Q

Donor Egg

A
  • one for mitochondria problems, moms nucleus put in donor egg
  • or can just carry a donated egg